Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases

References

• World Health Organization. World Health Statistics 2016: Monitoring Health for the SDGs Sustainable Development Goals. World Health Organization; 2016.
   Google Scholar
• Dimmeler S. Cardiovascular disease review series. EMBO Mol Med. 2011;3(12):697. doi:10.1002/emmm.201100182
   PubMedGoogle Scholar
• Stewart J, Manmathan G, Wilkinson P. Primary prevention of cardiovascular disease: a review of contemporary guidance and literature. JRSM Cardiovasc Dis. 2017;6:2048004016687211. doi:10.1177/2048004016687211
   Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:1376. Massachusetts Medical Society. doi:10.1056/NEJM200005043421819
   Google Scholar
• Martín Giménez VM, Kassuha DE, Manucha W. Nanomedicine applied to cardiovascular diseases: latest developments. Ther Adv Cardiovasc Dis. 2017;11(4):133–142. doi:10.1177/1753944717692293
   PubMedGoogle Scholar
• Radomska A, Leszczyszyn J, Radomski MW. The nanopharmacology and nanotoxicology of nanomaterials: new opportunities and challenges. Adv Clin Exp Med. 2016;25(1):151–162. doi:10.17219/acem/60879
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Iram F, Siddiqui S, Sahu K. Role of natural products in drug discovery process. Int J Drug Dev Res. 2014;6(2):172–204.
   Google Scholar
• Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559.
   PubMed Web of Science ®Google Scholar
• Clark AM. Natural products as a resource for new drugs. Pharm Res. 1996;13(8):1133–1144. doi:10.1023/a:1016091631721
   PubMed Web of Science ®Google Scholar
• Sorokina M, Steinbeck C. Review on natural products databases: where to find data in 2020. J Cheminform. 2020;12(1):1–51. doi:10.1186/s13321-020-00424-9
   PubMed Web of Science ®Google Scholar
• Mushtaq S, Abbasi BH, Uzair B, Abbasi R. Natural products as reservoirs of novel therapeutic agents. EXCLI J. 2018;17:420.
   PubMed Web of Science ®Google Scholar
• Rahimi HR, Nedaeinia R, Sepehri Shamloo A, Nikdoust S, Kazemi Oskuee R. Novel delivery system for natural products: nano-curcumin formulations. Avicenna J Phytomed. 2016;6(4):383–398.
   PubMed Web of Science ®Google Scholar
• Taghipour YD, Hajialyani M, Naseri R, et al. Nanoformulations of natural products for management of metabolic syndrome. Int J Nanomedicine. 2019;14:5303–5321. doi:10.2147/IJN.S213831
   PubMed Web of Science ®Google Scholar
• Moradi SZ, Momtaz S, Bayrami Z, Farzaei MH, Abdollahi M. Nanoformulations of herbal extracts in treatment of neurodegenerative disorders. Front Bioeng Biotechnol. 2020;8. doi:10.3389/fbioe.2020.00238
   PubMedGoogle Scholar
• Rosler A, Vandermeulen GW, Klok HA. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev. 2001;53(1):95–108. doi:10.1016/s0169-409x(01)00222-8
   PubMed Web of Science ®Google Scholar
• Karthikeyan A, Senthil N, Min T. Nanocurcumin: a promising candidate for therapeutic applications. Front Pharmacol. 2020;11. doi:10.3389/fphar.2020.00487
   Google Scholar
• Houacine C, Singh KK. 10 Nano resveratrol: a promising future nanonutraceutical. NanoNutraceuticals. 2018.
   Google Scholar
• Ahn K. The worldwide trend of using botanical drugs and strategies for developing global drugs. BMB Rep. 2017;50(3):111–116. doi:10.5483/bmbrep.2017.50.3.221
   PubMed Web of Science ®Google Scholar
• Dong TTX, Cui XM, Song ZH, et al. Chemical assessment of roots of panax notoginseng in China: regional and seasonal variations in its active constituents. J Agric Food Chem. 2003;51(16):4617–4623. doi:10.1021/jf034229k
   PubMed Web of Science ®Google Scholar
• Rao PR, Viswanath RK. Cardioprotective activity of silymarin in ischemia-reperfusion-induced myocardial infarction in albino rats. Exp Clin Cardiol. 2007;12(4):179–187.
   PubMedGoogle Scholar
• Yu B, Fang T-H, Lu G-H, Xu H-Q, Lu J-F. Beneficial effect of cyclovirobuxine D on heart failure rats following myocardial infarction. Fitoterapia. 2011;82(6):868–877. doi:10.1016/j.fitote.2011.04.016
   PubMedGoogle Scholar
• Giannouli M, Karagkiozaki V, Pappa F, Moutsios I, Gravalidis C, Logothetidis S. Fabrication of quercetin-loaded PLGA nanoparticles via electrohydrodynamic atomization for cardiovascular disease. Mater Today Proc. 2018;5(8):15998–16005. doi:10.1016/j.matpr.2018.05.044
   Google Scholar
• Dinda B, Dinda S, DasSharma S, Banik R, Chakraborty A, Dinda M. Therapeutic potentials of baicalin and its aglycone, baicalein against inflammatory disorders. Eur J Med Chem. 2017;131:68–80. doi:10.1016/j.ejmech.2017.03.004
   PubMed Web of Science ®Google Scholar
• Bremer AA. Resveratrol use in metabolic syndrome. Metab Syndr Relat Disord. 2014;12(10):493–495. doi:10.1089/met.2014.1505
   PubMed Web of Science ®Google Scholar
• Cook KM, Figg WD. Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 2010;60(4):222–243. doi:10.3322/caac.20075
   PubMed Web of Science ®Google Scholar
• Sun G-B, Qin M, Ye J, et al. Inhibitory effects of myricitrin on oxidative stress-induced endothelial damage and early atherosclerosis in ApoE-/- mice. Toxicol Appl Pharmacol. 2013;271(1):114–126. doi:10.1016/j.taap.2013.04.015
   PubMed Web of Science ®Google Scholar
• Hamza A, Amin A, Daoud S. The protective effect of a purified extract of Withania somnifera against doxorubicin-induced cardiac toxicity in rats. Cell Biol Toxicol. 2008;24(1):63–73. doi:10.1007/s10565-007-9016-z
   PubMed Web of Science ®Google Scholar
• Zanwar AA, Hegde MV, Bodhankar SL. Cardioprotective activity of flax lignan concentrate extracted from seeds of Linum usitatissimum in isoprenalin induced myocardial necrosis in rats. Interdiscip Toxicol. 2011;4(2):90–97. doi:10.2478/v10102-011-0016-8
   PubMedGoogle Scholar
• Li X, Fang Q, Tian X, et al. Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation. Mol Med Rep. 2017;16(4):4455–4462. doi:10.3892/mmr.2017.7169
   PubMedGoogle Scholar
• Campbell MS, Fleenor BS. The emerging role of curcumin for improving vascular dysfunction: a review. Crit Rev Food Sci Nutr. 2018;58(16):2790–2799. doi:10.1080/10408398.2017.1341865
   PubMed Web of Science ®Google Scholar
• Allijn IE, Czarny BMS, Wang X, et al. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Control Release. 2017;247:127–133. doi:10.1016/j.jconrel.2016.12.042
   PubMed Web of Science ®Google Scholar
• Cavia-Saiz M, Busto M, Pilar-Izquierdo M, Ortega Santamaría N, Perez-Mateos M, Muñiz P. Antioxidant properties, radical scavenging activity and biomolecule protection capacity of flavonoid naringenin and its glycoside naringin: a Comparative Study. J Sci Food Agric. 2010;90(7):1238–1244. doi:10.1002/jsfa.3959
   PubMed Web of Science ®Google Scholar
• Hernandez-Abreu O, Torres-Piedra M, Garcia-Jimenez S, et al. Dose-dependent antihypertensive determination and toxicological studies of tilianin isolated from Agastache mexicana. J Ethnopharmacol. 2013;146(1):187–191. doi:10.1016/j.jep.2012.12.029
   PubMedGoogle Scholar
• Guo X, Cao W, Yao J, et al. Cardioprotective effects of tilianin in rat myocardial ischemia-reperfusion injury. Mol Med Rep. 2014;11. doi:10.3892/mmr.2014.2954
   Google Scholar
• Stoll A, Seebeck E. Chemical investigations on alliin, the specific principle of garlic. Adv Enzymol Relat Subj Biochem. 1951;11:377–400. doi:10.1002/9780470122563.ch8
   PubMedGoogle Scholar
• Hashemzaei M, Delarami Far A, Yari A, et al. Anticancer and apoptosis‑inducing effects of quercetin in vitro and in vivo. Oncol Rep. 2017;38(2):819–828. doi:10.3892/or.2017.5766
   PubMed Web of Science ®Google Scholar
• Pereira M, Siba IP, Chioca LR, et al. Myricitrin, a nitric oxide and protein kinase C inhibitor, exerts antipsychotic-like effects in animal models. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(7):1636–1644. doi:10.1016/j.pnpbp.2011.06.002
   PubMed Web of Science ®Google Scholar
• Patra JK, Das FL. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16. doi:10.1186/s12951-018-0392-8
   PubMedGoogle Scholar
• Lombardo D, Kiselev MA, Caccamo MT. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine. J Nanomater. 2019;2019:1–26. doi:10.1155/2019/3702518
   Web of Science ®Google Scholar
• Gao W, Zhang L. Coating nanoparticles with cell membranes for targeted drug delivery. J Drug Target. 2015;23(7–8):619–626. doi:10.3109/1061186X.2015.1052074
   PubMed Web of Science ®Google Scholar
• Kayal S, Ramanujan RV. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C. 2010;30(3):484–490. doi:10.1016/j.msec.2010.01.006
   Web of Science ®Google Scholar
• Chomoucka J, Drbohlavova J, Huska D, Adam V, Kizek R, Hubalek J. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 2010;62(2):144–149. doi:10.1016/j.phrs.2010.01.014
   PubMed Web of Science ®Google Scholar
• Lundy DJ, Chen K-H, Toh EK-W, Hsieh PC-H. Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury. Sci Rep. 2016;6:25613. doi:10.1038/srep25613
   PubMed Web of Science ®Google Scholar
• Kumar VV, Chandrasekar D, Ramakrishna S, Kishan V, Rao YM, Diwan PV. Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics. Int J Pharm. 2007;335(1–2):167–175. doi:10.1016/j.ijpharm.2006.11.004
   PubMed Web of Science ®Google Scholar
• Broz P, Ben-Haim N, Grzelakowski M, Marsch S, Meier W, Hunziker P. Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin. J Cardiovasc Pharmacol. 2008;51(3):246–252. doi:10.1097/FJC.0b013e3181624aed
   PubMedGoogle Scholar
• La Francesca S. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications. Methodist Debakey Cardiovasc J. 2012;8(1):28–35. doi:10.14797/mdcj-8-1-28
   PubMedGoogle Scholar
• Binsalamah ZM, Paul A, Khan AA, Prakash S, Shum-Tim D. Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model. Int J Nanomedicine. 2011;6:2667–2678. doi:10.2147/IJN.S25175
   PubMed Web of Science ®Google Scholar
• Myerson J, He L, Lanza G, Tollefsen D, Wickline S. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis. J Thromb Haemost. 2011;9(7):1292–1300. doi:10.1111/j.1538-7836.2011.04339.x
   PubMedGoogle Scholar
• Waltenberger B, Mocan A, Šmejkal K, Heiss EH, Atanasov AG. Natural products to counteract the epidemic of cardiovascular and metabolic disorders. Molecules. 2016;21(6):807.
   PubMed Web of Science ®Google Scholar
• Sobhani Z, Reza Nami S, Ahmad Emami S, Sahebkar A, Javadi B. Medicinal plants targeting cardiovascular diseases in view of Avicenna. Curr Pharm Des. 2017;23(17):2428–2443.
   PubMedGoogle Scholar
• Petrovska BB. Historical review of medicinal plants’ usage. Pharmacogn Rev. 2012;6(11):1.
   PubMedGoogle Scholar
• Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research: executive summary of a workshop. Circulation. 2001;103(16):2038–2041.
   PubMedGoogle Scholar
• Jérôme C, Lecomte P. Recent advances in the synthesis of aliphatic polyesters by ring-opening polymerization. Adv Drug Deliv Rev. 2008;60(9):1056–1076.
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4(3):206–220.
   PubMed Web of Science ®Google Scholar
• Du Y, Liu P, Yuan Z, et al. Simultaneous qualitative and quantitative analysis of 28 components in Isodon rubescens by HPLC‐ESI‐MS/MS. J Sep Sci. 2010;33(4‐5):545–557.
   PubMedGoogle Scholar
• Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R, Yamada K. Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol. Thromb Res. 2001;101(6):445–453.
   PubMedGoogle Scholar
• Sanz MJ, Cortijo J, Morcillo EJ. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression. Pharmacol Ther. 2005;106(3):269–297.
   PubMed Web of Science ®Google Scholar
• Wang Y, Tang J, Zhu H, et al. Aqueous extract of Rabdosia rubescens leaves: forming nanoparticles, targeting P-selectin, and inhibiting thrombosis. Int J Nanomedicine. 2015;10:6905.
   PubMedGoogle Scholar
• Atale N, Jaiswal A, Chhabra A, et al. Phytochemical and antioxidant screening of Syzygium cumini seed extracts: a comparative study. J Pharm Res. 2011;4(12):4530–4532.
   Google Scholar
• Neha A, Vibha R. GC-MS analysis of bioactive components in the ethanolic and methanolic extract of Syzygium cumini. Int J Pharma Bio Sci. 2013;4(4).
   Google Scholar
• Atale N, Chakraborty M, Mohanty S, et al. Cardioprotective role of syzygium cumini against glucose-induced oxidative stress in H9C2 cardiac myocytes. Cardiovasc Toxicol. 2013;13. doi:10.1007/s12012-013-9207-1
   PubMedGoogle Scholar
• Atale N, Gupta K, Rani V. Protective effect of Syzygium cumini against pesticide-induced cardiotoxicity. Environ Sci Pollut Res. 2014;21(13):7956–7972.
   PubMedGoogle Scholar
• Atale N, Saxena S, Nirmala JG, Narendhirakannan RT, Mohanty S, Rani V. Synthesis and characterization of Sygyzium cumini nanoparticles for its protective potential in high glucose-induced cardiac stress: a green approach. Appl Biochem Biotechnol. 2017;181(3):1140–1154.
   PubMedGoogle Scholar
• Ferretti G, Bacchetti T, Belleggia A, Neri D. Cherry antioxidants: from farm to table. Molecules. 2010;15(10):6993–7005.
   PubMed Web of Science ®Google Scholar
• Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr. 2005;45(4):287–306.
   PubMed Web of Science ®Google Scholar
• Beconcini D, Fabiano A, Zambito Y, et al. Chitosan-based nanoparticles containing cherry extract from Prunus avium L. to improve the resistance of endothelial cells to oxidative stress. Nutrients. 2018;10(11). doi:10.3390/nu10111598
   PubMedGoogle Scholar
• Beconcini D, Fabiano A, Di Stefano R, et al. Cherry extract from Prunus avium L. to improve the resistance of endothelial cells to oxidative stress: mucoadhesive chitosan vs. poly (lactic-co-glycolic acid) nanoparticles. Int J Mol Sci. 2019;20(7):1759.
   PubMedGoogle Scholar
• Beconcini D, Felice F, Zambito Y, et al. Anti-inflammatory effect of cherry extract loaded in polymeric nanoparticles: relevance of particle internalization in endothelial cells. Pharmaceutics. 2019;11(10):500.
   PubMedGoogle Scholar
• Najafi M, Ghasemian E, Fathiazad F, Garjani A. Effects of total extract of dracocephalum moldavica on ischemia/reperfusion induced arrhythmias and infarct size in the isolated rat heart. Iran J Basic Med Sci. 2009;11(4):229–235. doi:10.22038/ijbms.2009.5186
   Google Scholar
• Yang LN, Xing JG, He CH, Yang PM. Chemical constituents of Dracocephalum moldavica L. and their pharmacological activities. World Clin Drugs. 2013;34(4):226–231.
   Google Scholar
• Jiang J, Yuan X, Wang T, et al. Antioxidative and cardioprotective effects of total flavonoids extracted from Dracocephalum moldavica L. against acute ischemia/reperfusion-induced myocardial injury in isolated rat heart. Cardiovasc Toxicol. 2014;14(1):74–82.
   PubMed Web of Science ®Google Scholar
• Tan M, He C, Jiang W, et al. Development of solid lipid nanoparticles containing total flavonoid extract from Dracocephalum moldavica L. and their therapeutic effect against myocardial ischemia–reperfusion injury in rats. Int J Nanomedicine. 2017;12:3253.
   PubMed Web of Science ®Google Scholar
• Ghayur MN, Gilani AH, Rasheed H, et al. Cardiovascular and airway relaxant activities of peony root extract. Can J Physiol Pharmacol. 2008;86(11):793–803. doi:10.1139/Y08-084
   PubMedGoogle Scholar
• Ibrar M, Khan MA, Nisar M, Khan M. Evaluation of Paeonia emodi for its cardioprotective potentials: an investigative study towards possible mechanism. J Ethnopharmacol. 2019;231:57–65.
   PubMedGoogle Scholar
• Ibrar M, Khan MA, Imran M. Evaluation of Paeonia emodi and its gold nanoparticles for cardioprotective and antihyperlipidemic potentials. J Photochem Photobiol B Biol. 2018;189:5–13.
   PubMedGoogle Scholar
• Li -Y-Y, Feng J, Zhang X-L, Cui -Y-Y. Pine bark extracts: nutraceutical, pharmacological, and toxicological evaluation. J Pharmacol Exp Ther. 2015;353(1):9–16.
   PubMedGoogle Scholar
• Park I-J, Cha S-Y, Kang M, et al. Effect of proanthocyanidin-rich extract from Pinus radiata bark on immune response of specific-pathogen-free white leghorn chickens. Poult Sci. 2011;90(5):977–982.
   PubMedGoogle Scholar
• Sudjarwo S, Anwar C, Eraiko K, Koerniasari WG. Cardioprotective activity of Chitosan-Pinus merkusii extract nanoparticles against lead acetate induced cardiac cell damage in rat. Rasayan J Chem. 2019;12:184–191. doi:10.31788/RJC.2019.1215049
   Google Scholar
• Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol. 2008;46(2):409–420. doi:10.1016/J.FCT.2007.09.085
   PubMed Web of Science ®Google Scholar
• Verma SK, Singh M, Jain P, Bordia A. Protective Effect of Ginger, Zingiber Officinale Rosc on Experimental Atherosclerosis in Rabbits. 2004.
   Google Scholar
• Young H-Y, Liao J-C, Chang Y-S, Luo Y-L, Lu M-C, Peng W-H. Synergistic effect of ginger and nifedipine on human platelet aggregation: a study in hypertensive patients and normal volunteers. Am J Chin Med. 2006;34(04):545–551.
   PubMedGoogle Scholar
• Ghayur MN, Gilani AH, Afridi MB, Houghton PJ. Cardiovascular effects of ginger aqueous extract and its phenolic constituents are mediated through multiple pathways. Vascul Pharmacol. 2005;43(4):234–241.
   PubMed Web of Science ®Google Scholar
• Al-Amin ZM, Thomson M, Al-Qattan KK, Peltonen-Shalaby R, Ali M. Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. Br J Nutr. 2006;96(4):660–666.
   PubMed Web of Science ®Google Scholar
• Borcan F, Chirita-Emandi A, Andreescu NI, et al. Synthesis and preliminary characterization of polyurethane nanoparticles with ginger extract as a possible cardiovascular protector. Int J Nanomedicine. 2019;14:3691.
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Waltenberger B, Pferschy-Wenzig E-M, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582–1614.
   PubMed Web of Science ®Google Scholar
• Hosseinzadeh L, Behravan J, Mosaffa F, Bahrami G, Bahrami AR, Karimi G. Effect of curcumin on doxorubicin-induced cytotoxicity in H9c2 cardiomyoblast cells. Iran J Basic Med Sci. 2011;14(1):49–56.
   Web of Science ®Google Scholar
• Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889–2895.
   PubMed Web of Science ®Google Scholar
• He Y, Yue Y, Zheng X, Zhang K, Chen S, Du Z. Curcumin, inflammation, and chronic diseases: how are they linked? Molecules. 2015;20(5):9183–9213.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818.
   PubMed Web of Science ®Google Scholar
• Rachmawati H, Soraya IS, Kurniati NF, Rahma A. In vitro study on antihypertensive and antihypercholesterolemic effects of a curcumin nanoemulsion. Sci Pharm. 2016;84(1):131–140.
   PubMedGoogle Scholar
• Tong F, Chai R, Jiang H, Dong B. In vitro/vivo drug release and antidiabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles. Int J Nanomedicine. 2018;13:1945.
   PubMed Web of Science ®Google Scholar
• Boarescu P-M, Boarescu I, Bocșan IC, et al. Antioxidant and anti-inflammatory effects of curcumin nanoparticles on drug-induced acute myocardial infarction in diabetic rats. Antioxidants. 2019;8(10):504.
   Web of Science ®Google Scholar
• Hardy N, Viola HM, Johnstone VPA, et al. Nanoparticle-mediated dual delivery of an antioxidant and a peptide against the L-type Ca2+ channel enables simultaneous reduction of cardiac ischemia-reperfusion injury. ACS Nano. 2015;9(1):279–289.
   PubMed Web of Science ®Google Scholar
• Ray A, Rana S, Banerjee D, et al. Improved bioavailability of targeted curcumin delivery efficiently regressed cardiac hypertrophy by modulating apoptotic load within cardiac microenvironment. Toxicol Appl Pharmacol. 2016;290:54–65.
   PubMedGoogle Scholar
• Rice KM, Manne NDPK, Kolli MB, et al. Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension. Artif Cells Nanomed Biotechnol. 2016;44(8):1909–1916.
   PubMed Web of Science ®Google Scholar
• Boarescu P-M, Boarescu I, Bocșan IC, et al. Curcumin nanoparticles protect against isoproterenol induced myocardial infarction by alleviating myocardial tissue oxidative stress, electrocardiogram, and biological changes. Molecules. 2019;24(15):2802.
   PubMedGoogle Scholar
• Ranjan AP, Mukerjee A, Helson L, Vishwanatha JK. Mitigating prolonged QT interval in cancer nanodrug development for accelerated clinical translation. J Nanobiotechnology. 2013;11(1):40.
   PubMedGoogle Scholar
• Boarescu P-M, Chirilă I, Bulboacă AE, et al. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev. 2019;2019.
   PubMedGoogle Scholar
• Taylor AJ, Kent SM, Flaherty PJ, Coyle LC, Markwood TT, Vernalis MN. ARBITER: arterial biology for the investigation of the treatment effects of reducing cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. Circulation. 2002;106(16):2055–2060.
   PubMed Web of Science ®Google Scholar
• Aydin U, Ugurlucan M, Gungor F, et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology. 2009;60(3):370–377. Sage Publications Sage CA: Los Angeles, CA. doi:10.1177/0003319708321102
   PubMedGoogle Scholar
• Olszanecki R, Jawień J, Gajda M, et al. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice. J Physiol Pharmacol. 2005;56(4):627–635.
   PubMed Web of Science ®Google Scholar
• Li X, Xiao H, Lin C, et al. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomedicine. 2019;14:649. doi:10.2147/IJN.S189819
   PubMed Web of Science ®Google Scholar
• Abdel-Mageid AD, Abou-Salem MES, Salaam NMHA, El-Garhy HAS. The potential effect of garlic extract and curcumin nanoparticles against complication accompanied with experimentally induced diabetes in rats. Phytomedicine. 2018;43:126–134. doi:10.1016/j.phymed.2018.04.039
   PubMed Web of Science ®Google Scholar
• Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1(3):295–305. doi:10.1002/cam4.35
   PubMed Web of Science ®Google Scholar
• Nabofa WEE, Alashe OO, Oyeyemi OT, et al. Cardioprotective effects of curcumin-nisin based poly lactic acid nanoparticle on myocardial infarction in guinea pigs. Sci Rep. 2018;8(1). doi:10.1038/s41598-018-35145-5
   PubMedGoogle Scholar
• Sunagawa Y, Wada H, Suzuki H, et al. A novel drug delivery system of oral curcumin markedly improves efficacy of treatment for heart failure after myocardial infarction in rats. Biol PharmBull. 2012;35(2):139–144.
   PubMed Web of Science ®Google Scholar
• Yadav YC, Pattnaik S, Swain K. Curcumin loaded mesoporous silica nanoparticles: assessment of bioavailability and cardioprotective effect. Drug Dev Ind Pharm. 2019;45(12):1889–1895. doi:10.1080/03639045.2019.1672717
   PubMed Web of Science ®Google Scholar
• Li J, Zhou Y, Zhang W, Bao C, Xie Z. Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles. Colloids Surf B Biointerfaces. 2017;153:174–182. doi:10.1016/j.colsurfb.2017.02.023
   PubMed Web of Science ®Google Scholar
• Simion V, Stan D, Constantinescu CA, et al. Conjugation of curcumin‐loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells. J Pharm Pharmacol. 2016;68(2):195–207. doi:10.1111/jphp.12513
   PubMedGoogle Scholar
• Zhang J, Wang Y, Bao C, et al. Curcumin‑loaded PEG‑PDLLA nanoparticles for attenuating palmitate‑induced oxidative stress and cardiomyocyte apoptosis through AMPK pathway. Int J Mol Med. 2019;44(2):672–682. doi:10.3892/ijmm.2019.4228
   PubMedGoogle Scholar
• Namdari M, Eatemadi A. Cardioprotective effects of curcumin-loaded magnetic hydrogel nanocomposite (nanocurcumin) against doxorubicin-induced cardiac toxicity in rat cardiomyocyte cell lines. Artif Cells Nanomed Biotechnol. 2017;45(4):731–739. doi:10.1080/21691401.2016.1261033
   PubMed Web of Science ®Google Scholar
• Du Preez R, Pahl J, Arora M, Ravi kumar MNV, Brown L, Panchal SK. Low-dose curcumin nanoparticles normalise blood pressure in male Wistar rats with diet-induced metabolic syndrome. Nutrients. 2019;11(7):1542. doi:10.3390/nu11071542
   PubMedGoogle Scholar
• Liu Y, Liu Q, Liu Y, Ju F, Ma Q, He Q. In vivo evaluation of enhanced drug carrier efficiency and cardiac anti-hypertrophy therapeutic potential of nano-curcumin encapsulated photo-plasmonic nanoparticles combined polymerized nano-vesicles: a novel strategy. J Photochem Photobiol B Biol. 2019;199:111619. doi:10.1016/j.jphotobiol.2019.111619
   PubMedGoogle Scholar
• Cheng L, Sun X, Hu C, et al. In vivo early intervention and the therapeutic effects of 20 (S)-ginsenoside Rg3 on hypertrophic scar formation. PLoS One. 2014;9(12):12. doi:10.1371/journal.pone.0113640
   Google Scholar
• Li L, Ni J, Li M, et al. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy. Drug Deliv. 2017;24(1):1617–1630. doi:10.1080/10717544.2017.1391893
   PubMed Web of Science ®Google Scholar
• Yang L, Wang B, Gan H, et al. Enhanced oral bioavailability and anti‐tumour effect of paclitaxel by 20 (s)‐ginsenoside Rg3 in vivo. Biopharm Drug Dispos. 2012;33(8):425–436. doi:10.1002/bdd.1806
   PubMed Web of Science ®Google Scholar
• Chen Z-H, Li J, Liu J, et al. Saponins isolated from the root of Panax notoginseng showed significant antidiabetic effects in KK-Ay mice. Am J Chin Med. 2008;36(05):939–951. doi:10.1142/S0192415X08006363
   PubMedGoogle Scholar
• Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol. 2009;122(1):143–148. doi:10.1016/j.jep.2008.12.012
   PubMedGoogle Scholar
• Zhang J, Han X, Li X, et al. Core-shell hybrid liposomal vesicles loaded with panax notoginsenoside: preparation, characterization and protective effects on global cerebral ischemia/reperfusion injury and acute myocardial ischemia in rats. Int J Nanomedicine. 2012;7:4299. doi:10.2147/IJN.S32385
   PubMed Web of Science ®Google Scholar
• Deng Y, Yang M, Xu F, et al. Combined salvianolic acid B and ginsenoside Rg1 exerts cardioprotection against ischemia/reperfusion injury in rats. PLoS One. 2015;10(8):e0135435. doi:10.1371/journal.pone.0135435
   PubMedGoogle Scholar
• Qiu J, Cai G, Liu X, Ma D. αvβ3 integrin receptor specific peptide modified, salvianolic acid B and panax notoginsenoside loaded nanomedicine for the combination therapy of acute myocardial ischemia. Biomed Pharmacother. 2017;96:1418–1426. doi:10.1016/j.biopha.2017.10.086
   PubMed Web of Science ®Google Scholar
• Yoo JS, Lee J, Jung JH, et al. SPECT/CT imaging of high-risk atherosclerotic plaques using integrin-binding RGD dimer peptides. Sci Rep. 2015;5(1):11752. doi:10.1038/srep11752
   PubMedGoogle Scholar
• Ikram M. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 1975;28(08):353–358. doi:10.1055/s-0028-1097869
   PubMedGoogle Scholar
• Pérez-Rubio KG, González-Ortiz M, Martínez-Abundis E, Robles-Cervantes JA, Espinel-Bermúdez MC. Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion. Metab Syndr Relat Disord. 2013;11(5):366–369. doi:10.1089/met.2012.0183
   PubMed Web of Science ®Google Scholar
• Gautam R, Jachak SM. Recent developments in anti-inflammatory natural products. Med Res Rev. 2009;29(5):767–820. doi:10.1002/med.20156
   PubMed Web of Science ®Google Scholar
• Huang Z, Han Z, Ye B, et al. Berberine alleviates cardiac ischemia/reperfusion injury by inhibiting excessive autophagy in cardiomyocytes. Eur J Pharmacol. 2015;762:1–10. doi:10.1016/j.ejphar.2015.05.028
   PubMed Web of Science ®Google Scholar
• Renugadevi J, Shagirtha K. In vivo and in vitro antioxidative efficacy of naringenin on cadmium-induced toxicity in rats. Res Rev a J Toxicol. 2013;3(3):9–16.
   Google Scholar
• Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79(5):727–747.
   PubMed Web of Science ®Google Scholar
• Maity S, Mukhopadhyay P, Kundu PP, Chakraborti AS. Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals—An in vitro and in vivo approach. Carbohydr Polym. 2017;170:124–132. doi:10.1016/j.carbpol.2017.04.066
   PubMed Web of Science ®Google Scholar
• Shulman M, Cohen M, Soto-Gutierrez A, et al. Enhancement of naringenin bioavailability by complexation with hydroxypropoyl-β-cyclodextrin. PLoS One. 2011;6(4):e18033. doi:10.1371/journal.pone.0018033
   PubMed Web of Science ®Google Scholar
• Fuior EV, Deleanu M, Constantinescu CA, et al. Functional role of VCAM-1 targeted flavonoid-loaded lipid nanoemulsions in reducing endothelium inflammation. Pharmaceutics. 2019;11(8):391. doi:10.3390/pharmaceutics11080391
   PubMedGoogle Scholar
• Yuan Y, Cao W, Hong Y, et al. Tilianin pretreatment prevents myocardial ischemia-reperfusion injury via preservation of mitochondrial function in rat heart. Phytomedicine. 2017;34:106–114. doi:10.1016/j.phymed.2017.08.007
   PubMedGoogle Scholar
• Cheng XM, Ma TY, Su L, et al. Separation and authentication of tilianin and quality standards of semen of Dracocephalum moldavia. Zhongguo Zhong Yao Za Zhi. 2015;40(10):1845–1849.
   PubMedGoogle Scholar
• Wang Y, Wang Y, Wang X, Hu P. Tilianin loaded ROS-scavenging nano-micelles protect H9c2 cardiomyocyte against hypoxia/reoxygenation-induced injury. J Cardiovasc Pharmacol. 2018;72(1):32–39. doi:10.1097/FJC.0000000000000587
   PubMed Web of Science ®Google Scholar
• Tang M, Hu P, Zheng Q, et al. Polymeric micelles with dual thermal and reactive oxygen species (ROS)-responsiveness for inflammatory cancer cell delivery. J Nanobiotechnology. 2017;15(1):39. doi:10.1186/s12951-017-0275-4
   PubMedGoogle Scholar
• Han R-M, Tian Y-X, Becker EM, Andersen ML, Zhang J-P, Skibsted LH. Puerarin and conjugate bases as radical scavengers and antioxidants: molecular mechanism and synergism with β-carotene. J Agric Food Chem. 2007;55(6):2384–2391. doi:10.1021/jf062796c
   PubMedGoogle Scholar
• Wong KH, Li GQ, Li KM, Razmovski-Naumovski V, Chan K. Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases. J Ethnopharmacol. 2011;134(3):584–607. doi:10.1016/j.jep.2011.02.001
   PubMed Web of Science ®Google Scholar
• Luo C-F, Yuan M, Chen M-S, et al. Determination of puerarin in rat plasma by rapid resolution liquid chromatography tandem mass spectrometry in positive ionization mode. J Chromatogr B. 2011;879(19):1497–1501. doi:10.1016/j.jchromb.2011.03.035
   PubMedGoogle Scholar
• Li W, Wu J, Zhang J, et al. Puerarin-loaded PEG-PE micelles with enhanced antiapoptotic effect and better pharmacokinetic profile. Drug Deliv. 2018;25(1):827–837. doi:10.1080/10717544.2018.1455763
   PubMed Web of Science ®Google Scholar
• Li W, Wu J, Xiang D, et al. Micelles loaded with puerarin and modified with triphenylphosphonium cation possess mitochondrial targeting and demonstrate enhanced protective effect against isoprenaline-induced H9c2 cells apoptosis. Int J Nanomedicine. 2019;14:8345. doi:10.2147/IJN.S219670
   PubMed Web of Science ®Google Scholar
• Shan D, Li J, Cai P, et al. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of α v β 3 integrin-overexpressing breast cancer cells. Drug Deliv Transl Res. 2015;5(1):15–26. doi:10.1007/s13346-014-0210-2
   PubMed Web of Science ®Google Scholar
• Yu J, Gu Y, Du KT, Mihardja S, Sievers RE, Lee RJ. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials. 2009;30(5):751–756. doi:10.1016/j.biomaterials.2008.09.059
   PubMed Web of Science ®Google Scholar
• Dong Z, Guo J, Xing X, Zhang X, Du Y, Lu Q. RGD modified and PEGylated lipid nanoparticles loaded with puerarin: formulation, characterization and protective effects on acute myocardial ischemia model. Biomed Pharmacother. 2017;89:297–304. doi:10.1016/j.biopha.2017.02.029
   PubMed Web of Science ®Google Scholar
• Liu X, Ding Y, Zhao B, et al. In vitro and in vivo evaluation of puerarin-loaded PEGylated mesoporous silica nanoparticles. Drug Dev Ind Pharm. 2016;42(12):2031–2037. doi:10.1080/03639045.2016.1190742
   PubMed Web of Science ®Google Scholar
• Larson A, Witman MAH, Guo Y, et al. Acute, quercetin-induced reductions in blood pressure in hypertensive individuals are not secondary to lower plasma angiotensin-converting enzyme activity or endothelin-1: nitric oxide. Nutr Res. 2012;32(8):557–564. doi:10.1016/j.nutres.2012.06.018
   PubMedGoogle Scholar
• Cai X, Fang Z, Dou J, Yu A, Zhai G. Bioavailability of quercetin: problems and promises. Curr Med Chem. 2013;20(20):2572–2582. doi:10.2174/09298673113209990120
   PubMed Web of Science ®Google Scholar
• Soloviev A, Stefanov A, Parshikov A, et al. Arrhythmogenic peroxynitrite-induced alterations in mammalian heart contractility and its prevention with quercetin-filled liposomes. Cardiovasc Toxicol. 2002;2(2):129–139. doi:10.1385/CT:2:2:129
   PubMedGoogle Scholar
• Cote B, Carlson LJ, Rao DA, Alani AWG. Combinatorial resveratrol and quercetin polymeric micelles mitigate doxorubicin induced cardiotoxicity in vitro and in vivo. J Control Release. 2015;213:128–133. doi:10.1016/j.jconrel.2015.06.040
   PubMed Web of Science ®Google Scholar
• Lozano O, Lázaro-Alfaro A, Silva-Platas C, et al. Nanoencapsulated quercetin improves cardioprotection during hypoxia-reoxygenation injury through preservation of mitochondrial function. Oxid Med Cell Longev. 2019;2019:1–14. doi:10.1155/2019/7683051
   Google Scholar
• Wang L, Feng M, Li Y, et al. Fabrication of superparamagnetic nano-silica@ quercetin-encapsulated PLGA nanocomposite: potential application for cardiovascular diseases. J Photochem Photobiol B Biol. 2019;196:111508. doi:10.1016/j.jphotobiol.2019.05.005
   PubMed Web of Science ®Google Scholar
• Waisundara VY, Hsu A, Tan BK-H, Huang D. Baicalin improves antioxidant status of streptozotocin-induced diabetic Wistar rats. J Agric Food Chem. 2009;57(10):4096–4102. doi:10.1021/jf8028539
   PubMed Web of Science ®Google Scholar
• Kong F, Luan Y, Zhang Z, Cheng G, Qi T, Sun C. Baicalin protects the myocardium from reperfusion‑induced damage in isolated rat hearts via the antioxidant and paracrine effect. Exp Ther Med. 2014;7(1):254–259. doi:10.3892/etm.2013.1369
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang J, Pan J. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Deliv. 2016;23(9):3696–3703. doi:10.1080/10717544.2016.1223218
   PubMed Web of Science ®Google Scholar
• Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv. 2014;11(8):1285–1298. doi:10.1517/17425247.2014.919253
   PubMed Web of Science ®Google Scholar
• Cottart C, Nivet‐Antoine V, Laguillier‐Morizot C, Beaudeux J. Resveratrol bioavailability and toxicity in humans. Mol Nutr Food Res. 2010;54(1):7–16. doi:10.1002/mnfr.200900437
   PubMed Web of Science ®Google Scholar
• Shahraki A, Bahadorikhalili S, Hashemzaei M, et al. Resveratrol nanocapsule as an efficient tool for blood pressure regulation: a study on metabolic syndrome induced mice. Biosci Biotechnol Res Commun. 2017;10(4):623–630. doi:10.21786/bbrc/10.4/4
   Google Scholar
• Carlson LJ, Cote B, Alani AWG, Rao DA. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity. J Pharm Sci. 2014;103(8):2315–2322. doi:10.1002/jps.24042
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu K, Zeng H, et al. Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity. Int J Nanomedicine. 2019;14:6061. doi:10.2147/IJN.S211130
   PubMed Web of Science ®Google Scholar
• Fei X, Chen X, Liang G, et al. Preparation, characterization, and biodistribution of breviscapine proliposomes in heart. J Drug Target. 2009;17(5):408–414. doi:10.1080/10611860902913380
   PubMed Web of Science ®Google Scholar
• Lu J, Cheng C, Zhao X, et al. PEG-scutellarin prodrugs: synthesis, water solubility and protective effect on cerebral ischemia/reperfusion injury. Eur J Med Chem. 2010;45(5):1731–1738. doi:10.1016/j.ejmech.2010.01.006
   PubMedGoogle Scholar
• Xiong F, Wang H, Geng K, Gu N, Zhu J. Optimized preparation, characterization and biodistribution in heart of breviscapine lipid emulsion. Chem Pharm Bull. 2010;58(11):1455–1460. doi:10.1248/cpb.58.1455
   PubMed Web of Science ®Google Scholar
• Lee Y-J, Lee YM, Lee C-K, Jung JK, Han SB, Hong JT. Therapeutic applications of compounds in the Magnolia family. Pharmacol Ther. 2011;130(2):157–176. doi:10.1016/j.pharmthera.2011.01.010
   PubMed Web of Science ®Google Scholar
• Yang S, Hsieh M, Tsai T, Hsu S. Effector mechanism of magnolol‐induced apoptosis in human lung squamous carcinoma CH27 cells. Br J Pharmacol. 2003;138(1):193–201. doi:10.1038/sj.bjp.0705024
   PubMed Web of Science ®Google Scholar
• Amorati R, Zotova J, Baschieri A, Valgimigli L. Antioxidant activity of magnolol and honokiol: kinetic and mechanistic investigations of their reaction with peroxyl radicals. J Org Chem. 2015;80(21):10651–10659. doi:10.1021/acs.joc.5b01772
   PubMedGoogle Scholar
• Yang B, Xu Y, Yu S, Huang Y, Lu L, Liang X. Anti-angiogenic and anti-inflammatory effect of Magnolol in the oxygen-induced retinopathy model. Inflamm Res. 2016;65(1):81–93. doi:10.1007/s00011-015-0894-x
   PubMedGoogle Scholar
• Liang X, Xing W, He J, et al. Magnolol administration in normotensive young spontaneously hypertensive rats postpones the development of hypertension: role of increased PPAR gamma, reduced TRB3 and resultant alleviative vascular insulin resistance. PLoS One. 2015;10(3).
   Google Scholar
• Liang C-J, Lee C-W, Sung H-C, et al. Magnolol reduced TNF-α-induced vascular cell adhesion molecule-1 expression in endothelial cells via JNK/p38 and NF-κB signaling pathways. Am J Chin Med. 2014;42(03):619–637. doi:10.1142/S0192415X14500402
   PubMedGoogle Scholar
• Chen CY, Wu C. Magnolol encapsulated by liposome in inhibiting smooth muscle cell proliferation. J Chinese Chem Soc. 2008;55(3):517–521. doi:10.1002/jccs.200800076
   Google Scholar
• Lee C-W, Hu -SC-S, Yen F-L, et al. Magnolol nanoparticles exhibit improved water solubility and suppress TNF-α-induced VCAM-1 expression in endothelial cells. J Biomed Nanotechnol. 2017;13(3):255–268. doi:10.1166/jbn.2017.2342
   PubMed Web of Science ®Google Scholar
• Ananingsih VK, Sharma A, Zhou W. Green tea catechins during food processing and storage: a review on stability and detection. Food Res Int. 2013;50(2):469–479. doi:10.1016/j.foodres.2011.03.004
   Web of Science ®Google Scholar
• Hong MH, Kim MH, Chang HJ, et al. (−)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-κB signaling. Life Sci. 2007;80(21):1957–1965. doi:10.1016/j.lfs.2007.02.024
   PubMedGoogle Scholar
• Hong J, Lu H, Meng X, Ryu J-H, Hara Y, Yang CS. Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Res. 2002;62(24):7241–7246.
   PubMed Web of Science ®Google Scholar
• Zhang J, Nie S, Martinez-Zaguilan R, Sennoune SR, Wang S. Formulation, characteristics and antiatherogenic bioactivities of CD36-targeted epigallocatechin gallate (EGCG)-loaded nanoparticles. J Nutr Biochem. 2016;30:14–23. doi:10.1016/j.jnutbio.2015.11.001
   PubMed Web of Science ®Google Scholar
• Zhang J, Nie S, Wang S. Nanoencapsulation enhances epigallocatechin-3-gallate stability and its antiatherogenic bioactivities in macrophages. J Agric Food Chem. 2013;61(38):9200–9209. doi:10.1021/jf4023004
   PubMed Web of Science ®Google Scholar
• Feng J, Li S, Chen H. Tanshinone IIA inhibits myocardial remodeling induced by pressure overload via suppressing oxidative stress and inflammation: possible role of silent information regulator 1. Eur J Pharmacol. 2016;791:632–639. doi:10.1016/j.ejphar.2016.09.041
   PubMed Web of Science ®Google Scholar
• Gao S, Liu Z, Li H, Little PJ, Liu P, Xu S. Cardiovascular actions and therapeutic potential of tanshinone IIA. Atherosclerosis. 2012;220(1):3–10. doi:10.1016/j.atherosclerosis.2011.06.041
   PubMed Web of Science ®Google Scholar
• Li J, Liu P, Liu J-P, Zhang W-L, Yang J-K, Fan Y-Q. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation. Eur J Pharm Biopharm. 2012;80(2):426–432. doi:10.1016/j.ejpb.2011.11.003
   PubMedGoogle Scholar
• Zhang W, He H, Liu J, et al. Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins. Biomaterials. 2013;34(1):306–319. doi:10.1016/j.biomaterials.2012.09.058
   PubMed Web of Science ®Google Scholar
• Zhang S, Li J, Hu S, Wu F, Zhang X. Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction. Int J Nanomedicine. 2018;13:4045. doi:10.2147/IJN.S165590
   PubMed Web of Science ®Google Scholar
• Mao S, Wang L, Chen P, Lan Y, Guo R, Zhang M. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-κB pathway. Artif Cells Nanomed Biotechnol. 2018;46(sup3):S707–S716. doi:10.1080/21691401.2018.1508028
   PubMed Web of Science ®Google Scholar
• Badore N, Das P, Pillai S, Thakur A. Role of Ginkgo biloba extract, against isoproterenol induced cardiac toxicity in rats. Indian J Pharm Educ Res. 2017;51(4s):s691–s699. doi:10.5530/ijper.51.4s.100
   Google Scholar
• Oyama Y, Fuchs PA, Katayama N, Noda K. Myricetin and quercetin, the flavonoid constituents of Ginkgo biloba extract, greatly reduce oxidative metabolism in both resting and Ca(2+)-loaded brain neurons. Brain Res. 1994;635(1–2):125–129. doi:10.1016/0006-8993(94)91431-1
   PubMedGoogle Scholar
• Roy S, Chaudhuri T. A quantitative assessment of bioactive phytochemicals of Nerium indicum: an ethnopharmacological herb. Int J Res Pharm Sci. 2012;3:579–587.
   Google Scholar
• Ahmed Q, Gupta N, Kumar A, Nimesh S. Antibacterial efficacy of silver nanoparticles synthesized employing Terminalia arjuna bark extract. Artif Cells Nanomed Biotechnol. 2017;45(6):1–9. doi:10.1080/21691401.2016.1215328
   PubMed Web of Science ®Google Scholar
• Aqil F, Ahmad I, Mehmood Z. Antioxidant and free radical scavenging properties of twelve traditionally used Indian medicinal plants. Turkish J Biol. 2006;30:177–183.
   Google Scholar
• Aa A, Pb K, Pattiyappan S, Ra U, Peo R. Phytochemical screening of Sesbania grandiflora (Linn). Int J Biosci Nanosci. 2014;1:2014.
   Google Scholar
• Hamid K, Ng I, Tallapragada VJ, et al. An investigation of the differential effects of ursane triterpenoids from Centella asiatica, and their semisynthetic analogues, on GABAA receptors. Chem Biol Drug Des. 2016;88(3):386–397. doi:10.1111/cbdd.12766
   PubMed Web of Science ®Google Scholar
• Mridula K, Parthibhan S, Kumar T, Rao M. In vitro organogenesis from Tinospora cordifolia (Willd.) Miers — a highly valuable medicinal plant. S Afr J Bot. 2017;113:84–90. doi:10.1016/j.sajb.2017.08.003
   Google Scholar
• Upadhyay AK, Kumar K, Kumar A, Mishra HS. Tinospora cordifolia (Willd.) Hook. f. and Thoms. (Guduchi) - validation of the Ayurvedic pharmacology through experimental and clinical studies. Int J Ayurveda Res. 2010;1(2):112–121. doi:10.4103/0974-7788.64405
   PubMedGoogle Scholar
• Nitika G, Meena A, Jaspreet N. Evaluation of physicochemical and preliminary phytochemical studies on the root of bombax ceiba linn. Int Res J Pharm. 2011;924–926.
   Google Scholar
• Patel S, Verma N, Rathore B, Nayak G, Singhai A, Singh P. Cardioprotective effect of Bombax ceiba flowers against acute adriamycin-induced myocardial infarction in rats. Rev Bras Farmacogn. 2011;21(4):704–709. doi:10.1590/S0102-695X2011005000090
   Google Scholar
• Helal AM, Nakamura N, El-Askary H, Hattori M. Sesquiterpene lactone glucosides from Sonchus asper. Phytochemistry. 2000;53(4):473–477. doi:10.1016/S0031-9422(99)00516-6
   PubMedGoogle Scholar
• Khan M. Prevention of KBrO3-induced cardiotoxicity by Sonchus asper in rat. J Med Plant Res. 2011.
   Google Scholar
• Juhasz B, Kertesz A, Balla J, et al. Cardioprotective effects of sour cherry seed extract (SCSE) on the hypercholesterolemic rabbit heart. Curr Pharm Des. 2013;19(39):6896–6905. doi:10.2174/138161281939131127120517
   PubMedGoogle Scholar
• Yaqoob D. Paeonia Emodi: An Ethnopharmacological and Phytochemical Review. 2017.
   Google Scholar